Bendic Health Care Private Limited

Vidben-M Tablets combine Vildagliptin 50 mg, a DPP-4 inhibitor, with Metformin 500 mg, a biguanide, to deliver effective and sustained control of Type 2 Diabetes Mellitus. This dual-action formulation improves glycemic regulation by enhancing incretin activity, increasing insulin sensitivity, and reducing hepatic glucose production—supporting balanced blood sugar control throughout the day.

Key Benefits & Uses:

• Improves fasting and post-prandial blood glucose levels

• Supports meaningful HbA1c reduction

• Low risk of hypoglycemia when used appropriately

• Helps improve insulin sensitivity and metabolic control

• Suitable as initial combination or add-on therapy

Why Choose Vidben-M:

• Proven DPP-4 inhibitor + Metformin synergy

• Convenient dosing for better patient adherence

• Manufactured under stringent quality standards by Bendic Healthcare Pvt. Ltd.

Ideal For:
Diabetologists, physicians, hospitals, and retail pharmacies seeking a reliable Vildagliptin + Metformin tablet for comprehensive Type 2 diabetes managemen